Insider Trading & Ownership - Buell Jennifer

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Buell Jennifer

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-11-14
Option Award
2024-11-18
4:05 pm
N/A
2034-11-14
AGENUS INCAGENBuell Jennifer
Chairman Executive Council
300,000$0300,000
(Direct)
View

Ownership
2024-06-20
4:05 pm
N/A
N/A
AGENUS INCAGENBuell Jennifer
Chairman Executive Council
0$0246,168
(Direct)
View
2024-03-25
Option Award
2024-03-29
9:29 pm
N/A
2034-03-25
Protagenic Therapeutics Inc.PTIXBuell Jennifer
Director
75,000$1.7475,000
(Direct)
View
2024-01-16
Option Award
2024-01-18
8:00 pm
N/A
2034-01-16
MiNK Therapeutics Inc.INKTBuell Jennifer
Chief Executive Officer
1,160,919$01,160,919
(Direct)
View
2023-10-11
Other
2023-10-13
8:18 pm
N/A
N/A
MiNK Therapeutics Inc.INKTBuell Jennifer
Chief Executive Officer
695,750$0927,915
(Direct)
View
2023-10-11
Option Award
2023-10-13
8:18 pm
N/A
N/A
MiNK Therapeutics Inc.INKTBuell Jennifer
Chief Executive Officer
695,750$0927,915
(Direct)
View
2023-10-03
Tax Withholding
2023-10-03
9:15 pm
N/A
N/A
MiNK Therapeutics Inc.INKTBuell Jennifer
Chief Executive Officer
65,000$0.9449927,915
(Direct)
View
2023-10-02
Tax Withholding
2023-10-03
9:15 pm
N/A
N/A
MiNK Therapeutics Inc.INKTBuell Jennifer
Chief Executive Officer
58,550$1.0445927,915
(Direct)
View
2023-09-29
Tax Withholding
2023-10-03
9:15 pm
N/A
N/A
MiNK Therapeutics Inc.INKTBuell Jennifer
Chief Executive Officer
25,000$1.1538927,915
(Direct)
View
2023-09-27
Exercise
2023-09-29
4:30 pm
N/A
N/A
MiNK Therapeutics Inc.INKTBuell Jennifer
Chief Executive Officer
695,750$01,772,215
(Direct)
View
2023-01-09
Option Award
2023-01-11
4:58 pm
N/A
N/A
MiNK Therapeutics Inc.INKTBuell Jennifer
Chief Executive Officer
171,990$2.32880,715
(Direct)
View
2023-01-09
Option Award
2023-01-11
4:58 pm
N/A
2033-01-09
MiNK Therapeutics Inc.INKTBuell Jennifer
Chief Executive Officer
500,000$0880,715
(Direct)
View
2022-01-21
Option Award
2022-01-25
5:20 pm
N/A
2032-01-21
MiNK Therapeutics Inc.INKTBuell Jennifer
See Remarks
679,800$0679,800
(Direct)
View

Ownership
2021-10-20
6:53 pm
N/A
N/A
MiNK Therapeutics Inc.INKTBuell Jennifer
See Remarks
0$01,808,950
(Direct)
View
2021-06-30
Option Award
2021-07-02
7:34 pm
N/A
N/A
AGENUS INCAGENBuell Jennifer
COO and President
10,597$5.491,027,091
(Direct)
View
2021-06-15
Option Award
2021-07-02
7:34 pm
N/A
2030-12-17
AGENUS INCAGENBuell Jennifer
COO and President
900,000$01,027,091
(Direct)
View
2021-04-02
Option Award
2021-04-05
09:06 am
N/A
N/A
AGENUS INCAGENBuell Jennifer
President & COO
80,838$2.87116,494
(Direct)
View
2020-12-17
Option Award
2020-12-21
12:41 pm
N/A
2030-12-17
AGENUS INCAGENBuell Jennifer
COO and President
900,000$0900,000
(Direct)
View
2020-07-18
Option Award
2020-07-21
5:06 pm
2020-07-18
2030-07-18
Protagenic Therapeutics Inc.PTIXBuell Jennifer
Director
145,000$1.75145,000
(Direct)
View
2020-06-15
Option Award
2020-06-17
4:01 pm
N/A
2030-06-15
AGENUS INCAGENBuell Jennifer
COO and President
10,000$010,000
(Direct)
View
2019-12-24
Option Award
2019-12-27
12:58 pm
N/A
2029-12-24
AGENUS INCAGENBuell Jennifer
Chief Operating Officer
500,000$0500,000
(Direct)
View